238 related articles for article (PubMed ID: 27351426)
1. Targeting of Micelles and Liposomes Loaded with the Pro-Apoptotic Drug, NCL-240, into NCI/ADR-RES Cells in a 3D Spheroid Model.
Pattni BS; Nagelli SG; Aryasomayajula B; Deshpande PP; Kulkarni A; Hartner WC; Thakur G; Degterev A; Torchilin VP
Pharm Res; 2016 Oct; 33(10):2540-51. PubMed ID: 27351426
[TBL] [Abstract][Full Text] [Related]
2. Combination Nanopreparations of a Novel Proapoptotic Drug - NCL-240, TRAIL and siRNA.
Riehle R; Pattni B; Jhaveri A; Kulkarni A; Thakur G; Degterev A; Torchilin V
Pharm Res; 2016 Jul; 33(7):1587-601. PubMed ID: 26951567
[TBL] [Abstract][Full Text] [Related]
3. Erratum to: Targeting of Micelles and Liposomes Loaded with the Pro-Apoptotic Drug, NCL-240, into NCI/ADR-RES Cells in a 3D Spheroid Model.
Pattni BS; Nagelli SG; Aryasomayajula B; Deshpande PP; Kulkarni A; Hartner WC; Thakur G; Degterev A; Torchilin VP
Pharm Res; 2016 Nov; 33(11):2845-2846. PubMed ID: 27599990
[No Abstract] [Full Text] [Related]
4. Cytotoxicity of PEGylated liposomes co-loaded with novel pro-apoptotic drug NCL-240 and the MEK inhibitor cobimetinib against colon carcinoma in vitro.
Sriraman SK; Geraldo V; Luther E; Degterev A; Torchilin V
J Control Release; 2015 Dec; 220(Pt A):160-168. PubMed ID: 26497930
[TBL] [Abstract][Full Text] [Related]
5. The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors.
Sarisozen C; Abouzeid AH; Torchilin VP
Eur J Pharm Biopharm; 2014 Oct; 88(2):539-50. PubMed ID: 25016976
[TBL] [Abstract][Full Text] [Related]
6. Transferrin-Modified Vitamin-E/Lipid Based Polymeric Micelles for Improved Tumor Targeting and Anticancer Effect of Curcumin.
Muddineti OS; Kumari P; Ghosh B; Biswas S
Pharm Res; 2018 Mar; 35(5):97. PubMed ID: 29541866
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells.
Sriraman SK; Pan J; Sarisozen C; Luther E; Torchilin V
Mol Pharm; 2016 Feb; 13(2):428-37. PubMed ID: 26702994
[TBL] [Abstract][Full Text] [Related]
8. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
[TBL] [Abstract][Full Text] [Related]
9. The reversal of multidrug resistance in ovarian carcinoma cells by co-application of tariquidar and paclitaxel in transferrin-targeted polymeric micelles.
Zou W; Sarisozen C; Torchilin VP
J Drug Target; 2017 Mar; 25(3):225-234. PubMed ID: 27616277
[TBL] [Abstract][Full Text] [Related]
10. Targeted transferrin-modified polymeric micelles: enhanced efficacy in vitro and in vivo in ovarian carcinoma.
Sawant RR; Jhaveri AM; Koshkaryev A; Zhu L; Qureshi F; Torchilin VP
Mol Pharm; 2014 Feb; 11(2):375-81. PubMed ID: 24325630
[TBL] [Abstract][Full Text] [Related]
11. Transferrin-targeted polymeric micelles co-loaded with curcumin and paclitaxel: efficient killing of paclitaxel-resistant cancer cells.
Abouzeid AH; Patel NR; Sarisozen C; Torchilin VP
Pharm Res; 2014 Aug; 31(8):1938-45. PubMed ID: 24522815
[TBL] [Abstract][Full Text] [Related]
12. Targeting energy metabolism of cancer cells: Combined administration of NCL-240 and 2-DG.
Pattni BS; Jhaveri A; Dutta I; Baleja JD; Degterev A; Torchilin V
Int J Pharm; 2017 Oct; 532(1):149-156. PubMed ID: 28844900
[TBL] [Abstract][Full Text] [Related]
13. Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma.
Yuan M; Qiu Y; Zhang L; Gao H; He Q
Drug Deliv; 2016 May; 23(4):1171-83. PubMed ID: 26036724
[TBL] [Abstract][Full Text] [Related]
14. The anti-tumoral efficacy of a docetaxel-loaded liposomal drug delivery system modified with transferrin for ovarian cancer.
Yuan MQ; Zhu F; Lou JY; Yuan WM; Fu L; Liu S; Zhang ZZ; Liu CY; He Q
Drug Res (Stuttg); 2014 Apr; 64(4):195-202. PubMed ID: 24154938
[TBL] [Abstract][Full Text] [Related]
15. Nanomedicine based curcumin and doxorubicin combination treatment of glioblastoma with scFv-targeted micelles: In vitro evaluation on 2D and 3D tumor models.
Sarisozen C; Dhokai S; Tsikudo EG; Luther E; Rachman IM; Torchilin VP
Eur J Pharm Biopharm; 2016 Nov; 108():54-67. PubMed ID: 27569031
[TBL] [Abstract][Full Text] [Related]
16. Transferrin-anchored poly(lactide) based micelles to improve anticancer activity of curcumin in hepatic and cervical cancer cell monolayers and 3D spheroids.
Kumari P; Rompicharla SVK; Muddineti OS; Ghosh B; Biswas S
Int J Biol Macromol; 2018 Sep; 116():1196-1213. PubMed ID: 29753013
[TBL] [Abstract][Full Text] [Related]
17. Anti-cancer activity of doxorubicin-loaded liposomes co-modified with transferrin and folic acid.
Sriraman SK; Salzano G; Sarisozen C; Torchilin V
Eur J Pharm Biopharm; 2016 Aug; 105():40-9. PubMed ID: 27264717
[TBL] [Abstract][Full Text] [Related]
18. Targeted adriamycin delivery to MXT-B2 metastatic mammary carcinoma cells by transferrin liposomes: effect of adriamycin ADR-to-lipid ratio.
Lopez-Barcons LA; Polo D; Llorens A; Reig F; Fabra A
Oncol Rep; 2005 Nov; 14(5):1337-43. PubMed ID: 16211306
[TBL] [Abstract][Full Text] [Related]
19. Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma.
Jhaveri A; Deshpande P; Pattni B; Torchilin V
J Control Release; 2018 May; 277():89-101. PubMed ID: 29522834
[TBL] [Abstract][Full Text] [Related]
20. Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model.
Perche F; Patel NR; Torchilin VP
J Control Release; 2012 Nov; 164(1):95-102. PubMed ID: 22974689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
